Biogen (Germany) Market Value
| IDP Stock | EUR 155.25 1.75 1.11% |
| Symbol | Biogen |
Biogen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biogen.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in Biogen on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding Biogen Inc or generate 0.0% return on investment in Biogen over 30 days. Biogen is related to or competes with Merck, Roche Holding, Bayer Aktiengesellscha, ASTELLAS PHARMA, Astellas Pharma, and CSPC PHARMACEUTGR. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative di... More
Biogen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biogen Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 6.22 | |||
| Value At Risk | (2.51) | |||
| Potential Upside | 2.41 |
Biogen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biogen's standard deviation. In reality, there are many statistical measures that can use Biogen historical prices to predict the future Biogen's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.48) | |||
| Treynor Ratio | (0.56) |
Biogen Inc Backtested Returns
Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Risk Adjusted Performance of (0.13), standard deviation of 1.52, and Mean Deviation of 1.23 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biogen is expected to be smaller as well. At this point, Biogen Inc has a negative expected return of -0.21%. Please make sure to confirm Biogen's maximum drawdown, kurtosis, day median price, as well as the relationship between the potential upside and daily balance of power , to decide if Biogen Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
Biogen Inc has very good reverse predictability. Overlapping area represents the amount of predictability between Biogen time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biogen Inc price movement. The serial correlation of -0.69 indicates that around 69.0% of current Biogen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 7.55 |
Biogen Inc lagged returns against current returns
Autocorrelation, which is Biogen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biogen's stock expected returns. We can calculate the autocorrelation of Biogen returns to help us make a trade decision. For example, suppose you find that Biogen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biogen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biogen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biogen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biogen stock over time.
Current vs Lagged Prices |
| Timeline |
Biogen Lagged Returns
When evaluating Biogen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biogen stock have on its future price. Biogen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biogen autocorrelation shows the relationship between Biogen stock current value and its past values and can show if there is a momentum factor associated with investing in Biogen Inc.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Biogen Stock
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out Biogen Correlation, Biogen Volatility and Biogen Alpha and Beta module to complement your research on Biogen. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.